In PC vs BPH, the top significantly regulated pathways included EIF2, eIF4 and p70S6K signaling, as well as FXR/RXR and LXR/RXR activation (Supplementary Table 11, Fig. 4c). The gene discussed is NR1H4; the disease is benign prostatic hyperplasia.